HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases

about

Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant.HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect.

P2860

Q52314663-580C35F5-4223-4942-8840-96AEC7298AF4 Q55430421-864FBAE4-14DC-4973-AE18-C9CF4F6D8E98

P2860

HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases

Item

http://www.wikidata.org/entity/Q37613447

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HE4 tumor marker concentration ...... benign gynecological diseases

@en

HE4 tumor marker concentration ...... benign gynecological diseases.

@nl

type

Item

label

HE4 tumor marker concentration ...... benign gynecological diseases

@en

HE4 tumor marker concentration ...... benign gynecological diseases.

@nl

prefLabel

HE4 tumor marker concentration ...... benign gynecological diseases

@en

HE4 tumor marker concentration ...... benign gynecological diseases.

@nl

P1476

HE4 tumor marker concentration ...... benign gynecological diseases

@en

P2093

Agnieszka Sompolska-Rzechuła

http://www.w3.org/2001/XMLSchema#string

Aneta Cymbaluk-Płoska

http://www.w3.org/2001/XMLSchema#string

Elżbieta Byra

http://www.w3.org/2001/XMLSchema#string

Izabella Rzepka-Górska

http://www.w3.org/2001/XMLSchema#string

P2860

WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas.

The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms.

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.

Malignant effusions: from diagnosis to biology.

HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines

Assessment of cells in the ascitic fluid of women with ovarian hyperstimulation syndrome: the clinical implications for subsequent ovarian malignancy

P2888

1757-2215-7-22

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1757-2215-7-22

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

A Chudecka-Głaz

Janusz Menkiszak

P577

2014-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260216585

http://www.w3.org/2001/XMLSchema#string

P6179

1048880767

http://www.w3.org/2001/XMLSchema#string

P698

24528554

http://www.w3.org/2001/XMLSchema#string

P932

3940276

http://www.w3.org/2001/XMLSchema#string

HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases

about

P2860

P2860

HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932